Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

ART Advanced Research Technologies Translational Imaging Platform Showcased at the World Molecular Imaging Congress in Montreal, Canada

ART Advanced Research Technologies Inc. ("ART") (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced that current research relating to its molecular imaging products will be presented at poster sessions at the World Molecular Imaging Congress (WMIC), being held at the Palais des congres in Montreal, Canada, from September 23 to 26, 2009. ART is also displaying its Optix, SoftScan and Fenestra product offering as an exhibitor at the event (booth #301), in the Exhibit Hall of the Palais des congres.

Prior to the start of the meeting - on Tuesday, September 22 - ART will hold a ART User Forum, where Optix users from major pharmaceutical companies and research institutes will present their work, and provide a hands-on opportunity for potential clients to learn about new developments and applications available for the Optix system, as well as the capability for translational research using the SoftScan breast imaging device. Both products are based on the proprietary time domain technology developed by ART, which allows for more accurate recovery of depth and concentration than other optical systems.

About ART Advanced Research Technologies

ART Advanced Research Technologies Inc. is a leader in molecular imaging products for the healthcare and pharmaceutical industries. ART has developed products in medical imaging, medical diagnostics, disease research, and drug discovery with the goal of bringing new and better treatments to patients faster. The Optix optical molecular imaging system, designed for monitoring physiological changes in living systems at the preclinical study phases of new drugs, is used by industry and academic leaders worldwide. The SoftScan optical medical imaging device is designed to improve the diagnosis and treatment of breast cancer. For more information on ART Advanced Research Technologies , visit our website at www.art.ca.